Humacyte, Inc. - Common Stock (HUMA)

CUSIP: 44486Q103

Q4 2023 13F Holders as of 31 Dec 2023

Holder snapshot 7 signals
Share change
+1,176,875
Put/Call ratio
191%
SEC-reported price per share
$2.84
Number of holders
87
Value change
+$3,312,296
Number of buys
43
Open additional details 1 more signal available
Number of sells
23
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
272,828,667

Security key

44486Q103

Report period

Q4 2023

Institutions

87

Top holders

10

Ownership snapshot

Top reported holders of HUMA - Humacyte, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Ayabudge LLC
Disclosed value leader
FRESENIUS MEDICAL CARE HO...
Comparable rows
0/15
Latest evidence
30 Sep 2023
3/4/5 13F Highest disclosed value: $21,792,154 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ has the largest disclosed position value at $21.79M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FRESENIUS MEDICAL CARE HOLDINGS INC /NY/'s linked filing trail.
Disclosed position value Top 5
Ayabudge LLC $9.75M
FRESENIUS MEDICAL CARE HOLDINGS I... $21.79M
BlackRock Finance, Inc. $13.19M
VANGUARD GROUP INC $8.85M
GEODE CAPITAL MANAGEMENT, LLC $3.6M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Ayabudge LLC
3/4/5
10%+ Owner
—
denominator unverified
$9,747,457
8,191,140 shares
— 17 Aug 2023
FRESENIUS MEDICAL CARE HOLDINGS INC /NY/
3/4/5
Former 10% Shareholder
—
denominator unverified
$21,792,154
18,312,735 shares
— 26 Aug 2021
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$13,186,422
4,500,486 shares
— 30 Sep 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$8,845,573
3,018,967 shares
— 30 Sep 2023
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
—
denominator unverified
$3,601,674
1,229,079 shares
— 30 Sep 2023
MILLENNIUM MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$3,593,378
1,226,409 shares
— 30 Sep 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
87
Shares
17,820,871
Rows available
87
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
83
Q4 2023 holders
87
Holder diff
4
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 value Q4 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .